Endocrine, Metabolic & Immune Disorders - Drug Targets(Formerly Current Dru

Various Non-Injectable Delivery Systems for the Treatment of Diabetes Mellitus
pp. 1-13(13)
Authors: Yadav, Neha; Morris, Gordon; Harding, S. E.; Ang, Shirley; Adams, G. G.

Interferon-Beta Therapy Monitoring in Multiple Sclerosis Patients
pp. 14-28(15)
Authors: Sottini, A.; Capra, R.; Serana, F.; Chiarini, M.; Caimi, L.; Imberti, L.

Cardiovascular Physiology of Androgens and Androgen Testosterone Therapy in Postmenopausal Women
pp. 29-37(9)
Authors: Ling, Shanhong; Komesaroff, Paul A.; Sudhir, Krishnankutty

p38 Mitogen-Activated Protein Kinase: A Critical Node Linking Insulin Resistance and Cardiovascular Diseases in Type 2 Diabetes Mellitus
pp. 38-46(9)
Authors: Liu, Zhenqi; Cao, Wenhong

Mutation, Selection and the Amino Acid Hydropathic Character: A Study on Receptor Genes Involved in Immune and Non-Immune Functions
pp. 47-66(20)
Authors: Panaro, Maria A.; Sisto, Margherita; Mitolo, Carlo I.; Cianciulli, Antonia; Mitolo, Vincenzo

Glucans as Biological Response Modifiers
pp. 67-75(9)
Authors: Novak, M.; Vetvicka, V.

A Novel Approach to Anticancer Therapies: Peroxisome Proliferator Activator-Receptor-γ as a New Target Therapy in the Treatment of Human Urological Cancer
pp. 76-83(8)
Authors: Matsuyama, M.; Yoshimura, R.

Targeting Histone Deacetylases for the Treatment of Immune, Endocrine & Metabolic Disorders
pp. 84-107(24)
Authors: Lawless, M. W.; Norris, S.; O'Byrne, K. J.; Gray, S. G.

Methodologic Issues in the Validation of Putative Biomarkers and Surrogate Endpoints in Treatment Evaluation for Systemic Lupus Erythematosus
pp. 108-112(5)
Authors: Liang, Matthew H.; Simard, Julia F.; Costenbader, Karen; Dore, Benjamin T.; Ward, Michael; Fortin, Paul R.; Illei, Gabor G.; Manzi, Susan; Mittleman, Barbara; Buyon, Jill; Gupta, Samardeep; Abrahamowicz, Michal